Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 6.00
-3.75 (-38.46%)
Oct 15, 2026, 4:25 PM GMT
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 7.51 million as of October 15, 2026. It is the 38,523rd most valuable company in the world and the 835th biggest in the United Kingdom. Its market cap has decreased by 51.06% in one year.
Market Cap
7.51M
Enterprise Value
6.80M
Revenue
2.11M
Global Rank
Country Rank
#835 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 7.51M, a decrease of -72.48%. That is a compound annual growth rate of -13.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 7.51M | -52.81% |
| Dec 31, 2025 | 15.91M | 135.22% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuPharma | 25.01M |
| IXICO | 18.61M |
| SkinBioTherapeutics | 14.97M |
| Oxford BioDynamics | 12.39M |
| Palatin Technologies | 12.26M |
| Aptamer Group | 11.87M |
| Thalia Therapeutics | 11.10M |
| Genflow Biosciences | 10.70M |